Ex Parte Bailey et al - Page 4


               Appeal No. 2006-0728                                                                      Page 4                  
               Application No. 10/198,714                                                                                        

               hematologic toxicity,” the court concluded that “this language is only a statement of                             
               purpose and intended result.  The expression does not result in a manipulative                                    
               difference in the steps of the claims.”  Id.                                                                      
                      In this case as well, the preamble of claim 1 does nothing more than express the                           
               purpose and intended result of the claimed method.  It does not change the method                                 
               defined in the body of the claim, e.g., by changing the way the manipulative steps of the                         
               method are carried out or the persons on whom the method is practiced.  Therefore, it is                          
               not a claim limitation.  We interpret claim 1 to be directed to a method comprising                               
               applying to the skin a composition in which a metal pyrithione is dispersed.                                      
                      Claim 8 adds the limitations that the skin is contacted with water before the metal                        
               pyrithione-containing composition, the excess metal pyrithione is rinsed off, and “the                            
               extent to which the level of lipids in the skin has increased” is determined.                                     
                      Claim 10 further limits claim 1 by requiring that the metal pyrithione is “in the form                     
               of particles having a size distribution in which 90% of the particles have a size of up to                        
               100 microns.”                                                                                                     
               2.  Anticipation                                                                                                  
                      The examiner rejected claims 1-6, 8, and 9 under 35 U.S.C. § 102(b) as                                     
               anticipated by Ramachandran.1  The examiner noted that Ramachandran “discloses                                    
               shampoo compositions containing anionic, amphoteric surfactants and active agents                                 
               such as zinc pyrithione, climbazole, etc., for treating hair or scalp itch or irritation.”                        
               Examiner’s Answer, page 3.                                                                                        


                                                                                                                                 
               1 Ramachandran et al., U.S. Patent 5,834,409, issued November 10, 1998.                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007